SEC Form D · Amendment · filed March 15, 2023
Orion Biotechnology Canada Ltd
Location
OTTAWA, ONTARIO, Z4
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Jason S. Burke · Ottawa, Ontario, CanadaExecJohn S. Jussup · Ottawa, Ontario, CanadaExecMark Groper · Ottawa, Ontario, CanadaExec · DirectorTheresa S. Firestone · Ottawa, Ontario, CanadaExecJean W. Forcione · Ottawa, Ontario, CanadaExecGary D. Reaves Ii · Houston, TXExec · DirectorAlex T. Krueger · Stamford, CTExecJohn A. Hill · Stamford, CTExecJohn W. Honeybourne · Houston, TXExecAnatolii Klepatskyi · Ottawa, Ontario, CanadaDirectorMark Hecht · Ottawa, Ontario, CanadaDirectorMclean W. Wilson · Memphis, TNExec · DirectorAngel Onuoha-Onyekuru · Conroe, TXExecGPE X GP Limited Partnership · Boston, MAExecTomasso Montagni · New York, NYExecJean W. Forcione · Ottawa, Ontario, CanadaExecAnatolii Klepatskyi · Ottawa, Ontario, CanadaDirectorMark Hecht · Ottawa, Ontario, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗